PKA phosphorylation of Src mediates cAMP's inhibition of cell growth via Rap1

John M Schmitt1, Philip J S Stork

  • 1Vollum Institute and Department of Cell and Developmental Biology, Oregon Health Sciences University, Portland, OR 97201, USA.

Molecular Cell
|January 24, 2002
PubMed

Insights

Cyclic AMP (cAMP) inhibits fibroblast cell growth by activating protein kinase A (PKA), which then activates Src tyrosine kinase. This pathway regulates cell proliferation and ERK signaling.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Signal Transduction

Background:

  • Cyclic AMP (cAMP) is a crucial second messenger that regulates various cellular processes.
  • cAMP antagonizes growth factor signaling pathways, including extracellular signal-regulated kinases (ERKs), and inhibits cell growth in fibroblasts.
  • The precise molecular mechanisms underlying cAMP's antiproliferative effects are not fully elucidated.

Purpose of the Study:

  • To investigate the role of protein kinase A (PKA) and the small G protein Rap1 in cAMP-mediated inhibition of ERK activation and cell growth.
  • To identify the specific signaling molecules and pathways involved in PKA's activation of Rap1.
  • To elucidate the function of Src tyrosine kinase in the cAMP signaling pathway.

Main Methods:

  • Fibroblast cell culture and stimulation.
  • Western blotting to detect protein phosphorylation and activation.
  • In vitro kinase assays.
  • Rap1 activation assays.
  • Cell proliferation assays.

Main Results:

  • PKA activation of Rap1 is mediated by a signaling complex including C3G, Crk-L, Cbl, and Src.
  • Src tyrosine kinase is essential for cAMP-induced activation of Rap1 and subsequent inhibition of ERKs and cell growth.
  • PKA directly phosphorylates Src at serine 17, which is critical for Src activation and the downstream signaling cascade.
  • This phosphorylation event is required for cAMP's inhibitory effects on ERK signaling and cell proliferation.

Conclusions:

  • Src tyrosine kinase plays an antiproliferative role in the physiological regulation of cell growth by cAMP.
  • The PKA-Src signaling axis represents a key pathway through which cAMP exerts its inhibitory effects on cell proliferation.
  • Understanding this pathway provides insights into potential therapeutic targets for diseases involving aberrant cell growth.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...